BioXcel Therapeutics (BTAI) P/E (2018 - 2026)
BioXcel Therapeutics (BTAI) P/E from Mar 8, 2018 to Jun 12, 2026. The TTM BioXcel Therapeutics (BTAI) P/E is -2.43. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of BioXcel Therapeutics (BTAI)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.43 | -14.62% |
| 2025 | -2.85 | +66.72% |
| 2024 | -1.71 | -99.08% |
| 2023 | -184.84 | -86.27% |
| 2022 | -1.35K | +5.66% |
| 2021 | -1.27K | -56.00% |
| 2020 | -2.89K | +216.22% |
| 2019 | -915.41 | +278.50% |
| 2018 | -241.85 | N/A |
Comparison BioXcel Therapeutics (BTAI) P/E with competitors
BioXcel Therapeutics (BTAI) P/E is -2.43.